Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 10, 2021 17:30 ET | Source: Genenta Science

Genenta Announces Filing of Registration Statement for Proposed Initial Public Offering

MILAN, Italy and NEW YORK, Nov. 10, 2021 (GLOBE NEWSWIRE) -- Genenta Science, a clinical-stage biotechnology company pioneering the development of hematopoietic stem progenitor cell immuno-gene...
September 30, 2021 07:00 ET | Source: Genenta Science

Genenta Strengthens Senior Management With Key Strategic Appointments

Gaurav Shah, Brad Loncar and Alec Ross appointed as strategic advisorsBarbara Regonini joins recently hired CFO, Richard Slansky, completing senior financial management team MILAN, Italy and NEW...
May 17, 2021 04:33 ET | Source: Genenta Science

Genenta Appoints Four Renowned Oncology Experts to Scientific Advisory Board

MILAN, Italy and NEW YORK, May 17, 2021 (GLOBE NEWSWIRE) -- Genenta Science, a clinical-stage biotechnology company pioneering the development of a hematopoietic stem cell gene therapy for cancer...
May 14, 2021 01:30 ET | Source: Genenta Science

Genenta Phase I/II Glioblastoma Data at ASGCT Show Temferon™ Delivered Tumor-Focused Interferon Expression

MILAN, Italy and NEW YORK, May 14, 2021 (GLOBE NEWSWIRE) -- Genenta Science, a clinical-stage biotechnology company pioneering the development of an investigational hematopoietic stem progenitor...
May 10, 2021 01:30 ET | Source: Genenta Science

Genenta to present at upcoming scientific congresses

MILAN, Italy and NEW YORK, May 10, 2021 (GLOBE NEWSWIRE) -- Genenta Science, a clinical-stage biotechnology company pioneering the development of a hematopoietic stem cell gene therapy for cancer...
May 03, 2021 01:30 ET | Source: Genenta Science

Genenta to Appoint Richard Slansky as CFO and Anthony Marucci as Board Member

MILAN, Italy and NEW YORK, May 03, 2021 (GLOBE NEWSWIRE) -- Genenta Science, a clinical-stage biotechnology company pioneering the development of a hematopoietic stem cell gene therapy for cancer...
January 05, 2021 08:49 ET | Source: Genenta Science

Genenta to Take Part in Gene Therapy Panel and Two Virtual Investor Events in January 2021

MILAN, Italy and NEW YORK, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Genenta Science, a clinical-stage biotechnology company pioneering the development of a hematopoietic stem cell gene therapy for cancer...
November 23, 2020 01:00 ET | Source: Genenta Science

Genenta to Appoint Stephen Squinto, Experienced Biotech Executive and Investor, as Chairman

MILAN, Italy and NEW YORK, Nov. 23, 2020 (GLOBE NEWSWIRE) -- Genenta Science, a clinical-stage biotechnology company pioneering the development of a hematopoietic stem progenitor cell gene therapy...
November 16, 2020 01:00 ET | Source: Genenta Science

Genenta’s Temferon™: Evidence of Controlled and Targeted Interferon Expression in Preliminary Phase I/II Clinical Data in Glioblastoma Multiforme

MILAN, Italy and NEW YORK, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Genenta Science, a clinical-stage biotechnology company pioneering the development of hematopoietic stem progenitor cell immuno-gene...
September 30, 2020 08:51 ET | Source: Genenta Science

Genenta to present preliminary Phase I/II clinical data on Temferon™ in glioblastoma multiforme at Chardan’s 4th Annual Genetic Medicines Conference

MILAN, Italy and NEW YORK, Sept. 30, 2020 (GLOBE NEWSWIRE) -- Genenta Science, a clinical-stage biotechnology company pioneering the development of a hematopoietic stem cell gene therapy for cancer...